According to a press release on October 12th from Canadian Health Department, Nicoventures Trading Limited, a subsidiary of British American Tobacco, has been granted a license to sell nicotine pouches called ZONNIC in Canada. This product aims to assist adult smokers in their efforts to quit smoking by delivering nicotine into their bodies. Imperial Tobacco Canada (ITCAN) will be the exclusive distributor of ZONNIC in Canada.
It is worth noting that ITCAN is a subsidiary of British American Tobacco and has no relation to the Imperial Tobacco brand. Frank Silva, President and CEO of ITCAN, commented on this.
This marks Canada's first approval of a nicotine pouch, as no other nicotine pouch has been authorized by the Canadian Department of Health.
According to reports, ZONNIC, a product that does not contain tobacco, is able to temporarily alleviate cravings and nicotine withdrawal symptoms. It has obtained Natural Health Product (NHP) approval and has been authorized by the Canadian Department of Health as a form of Nicotine Replacement Therapy (NRT) for sale.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
